Chooi KWai, Hou XLiang, Qu X, Soundararajan R, Uchegbu IF.  2013.  Claw amphiphiles with a dendrimer core: nanoparticle stability and drug encapsulation are directly proportional to the number of digits.. Langmuir. 29(13):4214-24.
Cassano R, Ferrarelli T, Schätzlein AG, Uchegbu IF, Trombino S.  2013.  Dextran-pegylated microparticles for enhanced cellular uptake of hydrophobic drugs.. Eur J Pharm Biopharm. 84(3):540-8.
Cruz IN, Zhang Y, de la Fuente M, Schätzlein A, Yang M.  2013.  Functional characterization of heat shock protein 90 targeted compounds.. Anal Biochem. 438(2):107-9.
Rahman KM, Jackson PJM, James CH, B Basu P, Hartley JA, de la Fuente M, Schätzlein A, Robson M, R Pedley B, Pepper C et al..  2013.  GC-targeted C8-linked pyrrolobenzodiazepine-biaryl conjugates with femtomolar in vitro cytotoxicity and in vivo antitumor activity in mouse models.. J Med Chem. 56(7):2911-35.
Welsh SJ, Dale AG, Lombardo CM, Valentine H, de la Fuente M, Schätzlein A, Neidle S.  2013.  Inhibition of the hypoxia-inducible factor pathway by a G-quadruplex binding small molecule.. Sci Rep. 3:2799.
Mazza M, Notman R, Anwar J, Rodger A, Hicks M, Parkinson G, McCarthy D, Daviter T, Moger J, Garrett N et al..  2013.  Nanofiber-based delivery of therapeutic peptides to the brain.. ACS Nano. 7(2):1016-26.
Uchegbu IF, Siew A.  2013.  Nanomedicines and nanodiagnostics come of age.. J Pharm Sci. 102(2):305-10.
Torrado JJ, Serrano DR, Uchegbu IF.  2013.  The oral delivery of amphotericin B.. Ther Deliv. 4(1):9-12.